SLU7 and cancer: Cancer-specific splicing events are established via different routes: 1) changes in expression levels, activity and localization of splice factors and/or 2) mutations in functional domains of splicing related proteins and/or mutations in regulatory sequences, such as enhancer/silencer sequences and branch points [22, 23].